Cost-related nonadherence by medication type among medicare part D beneficiaries with diabetes

Medical Care

Volumn 51, Issue 2, 2013, Pages 193-198

  Williams, Jessica ^a   Steers, William N ^b   Ettner, Susan L ^a,b   Mangione, Carol M ^a,b   Duru, Obidiugwu K ^b  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

diabetes; Medicare Part D; medication nonadherence

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; HYPOCHOLESTEROLEMIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; COST RELATED NONADHERENCE; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DRUG COST; FEMALE; GROUPS BY AGE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MEDICARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SELF REPORT; SOCIAL STATUS; TELECONSULTATION;

ADULT; AGE FACTORS; AGED; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; HYPOLIPIDEMIC AGENTS; INCOME; INTERVIEWS AS TOPIC; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MIDDLE AGED; RISK FACTORS; UNITED STATES;

EID: 84872839653     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318270dc52     Document Type: Article

References (40)

1. DiMatteo MD, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes: a meta-analysis. Med Care. 2002;40: 794-811.
2. Ho PM, Rumsfeld JM, Masoudi FA, et al. Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med. 2006;17:1836-1841.
3. Pladevall M, Williams LK, Potts LA, et al. Clinical outcomes and adherence to medications measured by claims data in patients with diabetes. Diabetes Care. 2004;27:2800-2805.
4. Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521-530.
5. Lau DT, Nau DP. Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes. Diabetes Care. 2004;27:2149-2153.
6. Piette JD, Wagner TH, Potter MB, et al. Health insurance status, costrelated medication underuse, and outcomes among diabetes patients in three systems of care. Med Care. 2004;42:102-109.
7. Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94:1782-1787.
8. Soumerai SB, Pierre-Jacques M, Zhang F, et al. Cost-related medication nonadherence among elderly and disabled Medicare beneficiaries: a national survey 1 year before the Medicare drug benefit. Arch Intern Med. 2006;166:1829-1835.
9. Madden JM, Graves JA, Zhang F, et al. Cost-related medication nonadherence and sending on basic needs following implementation of Medicare Part D. JAMA. 2008;299:1922-1928.
10. Gellad W, Haas J, Safran D. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22:1572-1578.
11. Landsman PB, Yu W, Liu X, et al. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. Am J Manag Care. 2005;11:621-628.
12. Chernew M, Gibson TB, Yu-Isenberg K, et al. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med. 2008;23:1131-1136.
13. Motheral BR, Henderson R. The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation. Am J Manag Care. 1999;5:1383-1394.
14. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298:61-69.
15. Johnson RE, Goodman MJ, Hornbrook MC, et al. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res. 1997;32:103-122.
16. Curtis JR, Xi J, Westfall JO, et al. Improving the prediction of medication compliance: the example of bisphosphonates for osteoporosis. Med Care. 2009;47:334-341.
17. Goldman DP, Joyce GR, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291:2344-2350.
18. Fairman KA, Motheral BR, Henderson RR. Retrospective, long-term follow-up study of the effect of a three-tier prescription drug copayment system on pharmaceutical and other medical utilization and costs. Clin Ther. 2003;25:3147-3161.
19. Persell SD, Heiman HL, Weingart SN, et al. Understanding of drug indications by ambulatory care patients. Am J Health Syst Pharm. 2004;61:2523-2527.
20. Duru OK, Mangione CM, Hsu J, et al. Generic-only drug coverage in the Medicare Part D gap and effect on medication cost-cutting behaviors for patients with diabetes mellitus: the translating research into action for diabetes study. J Am Geriatr Soc. 2010;58:822-828.
21. TRIAD Study Group. The Translating Research into Action for Diabetes (TRIAD) study: a multicenter study of diabetes in managed care. Diabetes Care. 2002;25:386-389.
22. Tseng CW, Brook RH, Keeler E, et al. Cost-lowering strategies used by Medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292:952-960.
23. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. 2nd ed. London: Sage Publications; 2011.
24. Cummings P. The relevant merits of risk ratios and odds ratios. Arch Pediatr Adolesc Med. 2009;163:438-445.
25. King G, Tomz M, Wittenberg J. Making the most of statistical analyses: improving interpretation and presentation. Am J Pol Sci. 2000;44: 341-355.
26. Train KE. Discrete Choice Methods with Simulation. Cambridge, UK: Cambridge University Press; 2003.
27. Kennedy JJ, Maciejewski M, Liu D, et al. Cost-related nonadherence in the Medicare program: the impact of Part D. Med Care. 2011;49: 522-526.
28. Madden JM, Graves AJ, Ross-Degnan D, et al. Cost-related medication nonadherence after implementation of Medicare Part D, 2006-2007. JAMA. 2009;302:1755-1756.
29. Benner JS, Glynn RJ, Mogun H, et al. Long-term persistence in use of statin therapy in elderly patients. JAMA. 2002;288:455-461.
30. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA. 2002;288:462-467.
31. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
32. Kaiser/HRET Survey of Employer Sponsored Health Benefits, 2005-2011. Available at: http://ehbs.kff.org/?page = charts&id = 2&sn = 23& ch = 2161. Accessed May 14, 2012.
33. Klein D, Turvey C, Wallace R. Elders who delay medication because of cost: health insurance, demographic, health, and financial correlates. Gerontologist. 2004;44:779-787.
34. Kaiser Family FoundationFact Sheet: low-income assistance under the Medicare Drug Benefit, 2006. Available at: http://www.allhealth.org/ briefingmaterials/Lowincomemedicareassistance-305.pdf. Accessed on September 19, 2012.
35. Lau DT, Briesacher BA, Touchette DR, et al. Medicare Part D and quality of prescription medication use in older adults. Drugs Aging. 2011;28:797-807.
36. Moczygemba LR, Barner JC, Lawson KA, et al. Impact of telephone medication therapy management on medication and health-related problems, medication adherence, and Medicare Part D drug costs: a 6-month follow up. Am J Geriatr Pharmacother. 2011;9:328-338.
37. Pellegrino AN, Martin MT, Tilton JJ, et al. Medication therapy management services: definitions and outcomes. Drugs. 2009;69: 393-406.
38. Bambauer KZ, Safran DG, Ross-Degnan D, et al. Depression and costrelated medication nonadherence in Medicare beneficiaries. Arch Gen Psychiatry. 2007;64:602-608.
39. Federal Interagency Forum on Aging-Related Statistics. Older Americans Update 2006: Key Indicators of Well-being. Washington, DC: US Government Printing Office Available at: http://www.agingstats.gov/agingstatsdotnet/Main- Site/Data/Data-2006.aspxAccessed March 30, 2012; 2006.
40. Ettner SL, Steers WN, Duru OK, et al. Entering and exiting the Medicare Part D coverage gap: role of comorbidities and demographics. J Gen Intern Med. 2010;25:568-574.